Global Bioenergies posts improved first-half 2024 results
Global Bioenergies, a company focused on sustainable fuels, reported a clear step forward in its financials for the first half of 2024. The company posted a net loss of €2.8 million—narrower than the €4.1 million loss recorded in the same period in 2023 and the €5.8 million loss in 2022. The direction is the story here: smaller losses year over year, tied to progress in ongoing projects and tighter financial management.
Cash flow and financial position
As of June 30, 2024, gross cash stood at €7.7 million. That’s down from €11.7 million at the end of the previous fiscal year. The decrease reflects the company’s effort to keep operations moving through the first half while dealing with day-to-day execution and market conditions. Even with the lower balance, management points to the ability to fund current workstreams and maintain operating capacity.
Management’s view
Chief Financial Officer Samuel Dubruque voiced cautious optimism about the first-half trend. He linked the reduced loss to funding secured through operating subsidies supporting major projects, including the Isoprod program. That program, backed by ADEME, remains central to the company’s operating model. “We started the year with a robust cash position and have made noteworthy advancements in consolidating our plant project,” he said, underscoring both the funding mix and the execution focus.
Update on the cosmetics plant project
Technical and commercial work on the cosmetics plant continued to advance during the first half. The planned unit is designed for a capacity of 2,500 tonnes per year to serve a growing market segment. Trials in larger fermenters supported the assumptions built into the business model, a key checkpoint before scaling. On the commercial side, the company received letters of intent from multiple potential customers. The level of interest, as described, exceeds the plant’s projected output, an early indicator of demand that will need to be matched by supply.
Progress in sustainable aviation fuel
On technology, one milestone stood out: extending the existing bio-SAF process to also produce e-SAF. The approach uses acetic acid as a synthetic resource and achieved a selectivity of more than 95%, meaning that almost all of the output can be marketed as jet fuel. That level of selectivity supports efficient production, with fewer by-products to manage. It also strengthens the company’s positioning as aviation fuel rules tighten in Europe, with EU mandates on fuel composition taking effect from 2030.
Public funding and the road ahead
Governmental support continues to play a role. One year after a €16.4 million grant from Bpifrance, Global Bioenergies is still working to add funding through both debt and equity, even as political and economic conditions remain challenging. The stated goal is to keep project timelines moving and to balance technology development with commercial readiness.
Long-term focus
Advances in SAF and e-SAF point to Global Bioenergies’ longer-term plan: develop technologies that answer climate and regulatory pressures while opening room for scale. The company frames its progress as both compliance-ready and market-facing—meeting standards, while aiming for a competitive product set in sustainable fuel.
Frequently Asked Questions
1. What net loss did Global Bioenergies report for the first half of 2024?
The company reported a net loss of €2.8 million for H1 2024.
2. How does the H1 2024 loss compare with prior years?
It’s narrower than the €4.1 million loss in H1 2023 and the €5.8 million loss in H1 2022, showing a continued reduction in losses.
3. What is Global Bioenergies’ cash position as of June 30, 2024?
Gross cash was €7.7 million at the end of June 2024, down from €11.7 million at the end of the previous fiscal year.
4. What progress has been made on the company’s plant projects?
The cosmetics plant project moved forward technically and commercially. Larger-fermenter runs supported the business model, and letters of intent from potential customers signaled demand that exceeds the plant’s planned 2,500-tonne-per-year capacity.
5. Who is the largest shareholder of Global Bioenergies?
L'Oréal is the largest shareholder, with a 13.5% stake in the company.
